Nucleoporin 35 regulates cardiomyocyte pH homeostasis by controlling Na+-H+exchanger-1 expression
Author(s) -
Liang Xu,
Lei Pan,
Jun Li,
Bijun Huang,
Jing Feng,
Chang Ming Li,
ShiYi Wang,
Erlinda The,
Yuan Liu,
Tianyou Yuan,
Lixiao Zhen,
Dandan Liang,
Yi Liu,
Li Li,
YingYu Cui,
Xiaoyan Jiang,
Luying Peng,
Yihan Chen
Publication year - 2015
Publication title -
journal of molecular cell biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.825
H-Index - 62
eISSN - 1674-2788
pISSN - 1759-4685
DOI - 10.1093/jmcb/mjv054
Subject(s) - nucleoporin , microbiology and biotechnology , intracellular ph , nuclear pore , intracellular , nuclear export signal , homeostasis , cytoplasm , sodium–hydrogen antiporter , extracellular , messenger rna , gene expression , downregulation and upregulation , biology , chemistry , nuclear transport , biochemistry , gene , cell nucleus , sodium , organic chemistry
The mammalian nuclear pore complex is comprised of ∼ 30 different nucleoporins (Nups). It governs the nuclear import of gene expression modulators and the export of mRNAs. In cardiomyocytes, Na(+)-H(+) exchanger-1 (NHE1) is an integral membrane protein that exclusively regulates intracellular pH (pHi) by exchanging one intracellular H(+) for one extracellular Na(+). However, the role of Nups in cardiac NHE1 expression remains unknown. We herein report that Nup35 regulates cardiomyocyte NHE1 expression by controlling the nucleo-cytoplasmic trafficking of nhe1 mRNA. The N-terminal domain of Nup35 determines nhe1 mRNA nuclear export by targeting the 5'-UTR (-412 to -213 nt) of nhe1 mRNA. Nup35 ablation weakens the resistance of cardiomyocytes to an acid challenge by depressing NHE1 expression. Moreover, we identify that Nup35 and NHE1 are simultaneously downregulated in ischemic cardiomyocytes both in vivo and in vitro. Enforced expression of Nup35 effectively counteracts the anoxia-induced intracellular acidification. We conclude that Nup35 selectively regulates cardiomyocyte pHi homeostasis by posttranscriptionally controlling NHE1 expression. This finding reveals a novel regulatory mechanism of cardiomyocyte pHi, and may provide insight into the therapeutic strategy for ischemic cardiac diseases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom